In breast cancer (BC) patients treated with anthracyclines-based therapies, we aim at assessing whether adjuvant drugs impact cardiac function differently and whether their cardiotoxicity has a regional pattern.

Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC)

Cadeddu Dessalvi, Christian;Deidda, Martino;
2021-01-01

Abstract

In breast cancer (BC) patients treated with anthracyclines-based therapies, we aim at assessing whether adjuvant drugs impact cardiac function differently and whether their cardiotoxicity has a regional pattern.
2021
Anthracyclines; Breast cancer; Cardiotoxicity; Myocardial strain
File in questo prodotto:
File Dimensione Formato  
Zito EurHJ Card.Imaging 2021.pdf

Solo gestori archivio

Tipologia: versione post-print (AAM)
Dimensione 487.6 kB
Formato Adobe PDF
487.6 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/305680
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 14
social impact